Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis

Wyeth

Status and phase: Completed; Phase 4

Conditions: Ankylosing Spondylitis

Treatments: Drug: etanercept; Drug: sulphasalazine (SSZ)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00247962

0881A3-402

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of etanercept and sulphasalazine in the treatment of Ankylosing Spondylitis.

Enrollment: 566 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of ankylosing spondylitis
• Active ankylosing spondylitis

Exclusion criteria

• Complete ankylosis of spine
• Previous treatment with etanercept

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

566 participants in 2 patient groups

A

Experimental group

Treatment:

Drug: etanercept

B

Active Comparator group

Treatment:

Drug: sulphasalazine (SSZ)